Search results
Author(s):
Benjamin H Holland
,
Robert J Applegate
Added:
3 years ago
Manual compression has been the gold standard for obtaining haemostasis at the femoral artery access site since being introduced in conjunction with the Seldinger technique in the 1950s.1 However, the limitations of manual compression, including patient discomfort, delayed haemostasis and ambulation and bleeding at the access site despite satisfactory initial haemostasis, have spurred the…
View more
Author(s):
Benjamin Galper
,
Roxana Mehran
Added:
3 years ago
Acute coronary syndromes (ACS) result from unstable coronary artery plaques that rupture and can lead to coronary ischaemia, unstable angina and myocardial infarction. The treatment goals in ACS focus on reducing ischaemia, preventing further progression of thrombotic plaque by disturbing the milieu of thrombosis and platelet aggregation taking place within the coronary artery and, in the case of…
View more
Author(s):
Steven V Manoukian
,
Michele D Voeltz
,
Frederick Feit
Added:
3 years ago
Non-ST-segment elevation (NSTE) acute coronary syndromes (ACS) include unstable angina (UA) and NSTE myocardial infarction (NSTEMI), and account for one and a half million hospitalisations in the US annually. Patients with ACS are typically managed by initial medical stabilisation followed by an early invasive approach, whereby cardiac catheterisation is performed, usually within 24 hours of…
View more
Author(s):
Biykem Bozkurt
Added:
1 month ago
Management of Haemostasis with Combined Use of Vascular Closure Devices and Bivalirudin - A Review
Author(s):
Emanuela de Cillis
,
Giuseppe Sangiorgi
,
Alessandro Santo Bortone
Added:
3 years ago
Article
Author(s):
Eunice NC Onwordi
,
Amr Gamal
,
Azfar Zaman
Added:
3 years ago
Acute coronary syndromes (ACS) are a major cause of morbidity and mortality. Despite the use of optimal medical therapy and revascularisation there remains a significant risk of vascular events. Registry data indicates a persistent risk even in patients who are event free in the first year following ACS, with as many as 1 in 5 patients suffering a vascular event in the subsequent 3 years.1
The…
View more
Author(s):
Eric W Holroyd
,
Chee W Khoo
,
Rob Butler
,
et al
Added:
3 years ago
Major bleeding or haemorrhage following a percutaneous coronary intervention (PCI) is not a benign event. There is now convincing evidence that it independently predicts increased mortality and adverse outcomes in patients.1,2 The adverse outcomes associated with a bleeding event are not just as a direct result of the haemorrhagic event, such as whether or not a patient survives their…
View more
Early Stent Thrombosis after Percutaneous Coronary Intervention for Acute Myocardial Infarction
Author(s):
Georgios J Vlachojannis
,
Bimmer E Claessen
,
George D Dangas
Added:
3 years ago
Article
Author(s):
Yohei Sotomi
,
Richard A Shlofmitz
,
Antonio Colombo
,
et al
Added:
3 years ago
From the early days of percutaneous coronary intervention (PCI) it became apparent that the presence of severe coronary calcification was a predictor of worse clinical outcomes. In the era of plain old balloon angioplasty, severe coronary calcification was associated with an increased risk of coronary dissection and procedural failure, while in the bare-metal stent era, it was associated with a…
View more
Author(s):
,
Adriano Caixeta
,
Gregg Stone
Added:
3 years ago
Accurate characterisation of coronary artery disease (CAD) anatomy based on the diagnostic angiogram is essential to select the optimal strategy of revascularisation. Recently, the SYNTAX score generated a great amount of interest because of its ability to risk-stratify and discriminate outcomes of patients with complex CAD undergoing percutaneous coronary intervention (PCI) as compared to…
View more